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Glomerular hemodynamic alterations during acute hyperinsulinemia in
normal and diabetic rats. Treatment of insulin dependent diabetes
invariably requires exogenous insulin to control blood glucose. Insulin
treatment, independent of other factors associated with insulin depen-
dent diabetes, may induce changes that affect glomerular function. Due
to exogenous delivery of insulin in insulin dependent diabetes entering
systemic circulation prior to the portal vein, plasma levels of insulin are
often in excess of that observed in non-diabetics. The specific effects of
hyperinsulinemia on glomerular hemodynamics have not been previ-
ously examined. Micropuncture studies were performed in control
(non-diabetic), untreated diabetic and insulin-treated diabetic rats 7 to
10 days after administration of 65 mglkg body weight streptozotocin.
After the first period micropuncture measurements were obtained, 5 U
of regular insulin (Humulin-R) was infused i.v., and glucose clamped at
euglycemic values (80 to 120 mg/dl). Blood glucose concentration in
non-diabetic controls was 99 6 mg/dl. In control rats, insulin infusion
and glucose clamp increased nephron filtration rate due to decreases in
both afferent and efferent arteriolar resistance (afferent greater than
efferent) resulting in increased plasma flow and increased glomerular
hydrostatic pressure gradient. However, insulin infusion and glucose
clamp produced the opposite effect in both untreated and insulin-treated
diabetic rats with afferent arteriolar vasoconstriction resulting in de-
creases in plasma flow, glomerular hydrostatic pressure gradient and
nephron filtration rate. Thromboxane A2 (TX) synthetase inhibition
partially decreased the vasoconstrictive response due to acute insulin
infusion in diabetic rats preventing the decrease in nephron filtration
rate. However, the action of TX inhibition decreased nephron filtration
rate prior to insulin infusion in both diabetic and control rats, which
may indicate participation of other neuro-humoral agents potentiated by
TX inhibition.
Insulin dependent diabetes prior to the onset of microalbu-
minuria and diabetic nephropathy is characterized by glomeru-
lar hyperfiltration and increased renal plasma flow [1, 2]. In
animal models, such as the streptozotocin induced diabetic rat,
Hostetter, Troy and Brenner [3] and others [4—6] have also
observed glomerular hypertension which has been postulated to
contribute to the development of glomerular microangiopathy,
albuminuria and eventually diabetes-induced end-stage renal
failure. However, the conditions in which glomerular hyperten-
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sion have been observed are those in which the animals are
moderately hyperglycemic and receiving daily doses of insulin
to maintain partial glycemic control [3, 7]. The progression of
diabetic nephropathy may be due to a variety of factors linked
to metabolic dysfunction or even to treatment of hyperglyce-
mia. Long term treatment of insulin dependent diabetes invari-
ably requires exogenous administration of insulin to control
blood glucose such that the action of exogenous insulin on renal
function is difficult to separate from that of diabetes. Exogenous
administration usually results in serum insulin concentrations
higher than that observed in normal subjects. The specific
effects of high plasma concentrations of insulin (hyperinsuline-
mia) on glomerular hemodynamics have not been previously
examined. The glomerulus exhibits high concentrations of
insulin receptors [6, 8,91 and stimulation of these receptors may
result in actions other than glucose transport as observed in
other vascular beds [10—12]. It is possible that exogenous
insulin administration may contribute to some of the observed
alterations in glomerular hemodynamics in partially-treated
diabetic rats.
Previous studies examining the effect of insulin on glomerular
hemodynamics have always carefully titrated the dose to re-
store hyperglycemic diabetic animals to euglycemic values with
doses in the U/min range [4, 13]. These studies may not have
utilized an adequate insulin dose to induce acute hyperinsuline-
mia, as could occur with typical insulin therapy, or to stimulate
insulin induced alterations in glomerular hemodynamics.
The present study was designed to examine the effects of
hyperinsulinemia on glomerular hemodynamics after seven to
ten days of streptozotocin induced diabetes in both untreated
and rats treated intensively with insulin. In addition, acute
insulin infusion at a dose 10 times the normal hourly secretion
rate of insulin in the normal, non-diabetic rat [14, 15] was
administered to examine the effects of hyperinsulinemia on
glomerular hemodynamics in normal rats. In addition, a non-
diabetic group and a group of untreated diabetic rats were given
a thromboxane A2 synthetase inhibitor to examine the role of
thromboxanes interacting with any vascular effect of hyperin-
sulinemia. Since high doses of insulin were utilized all rats were
glucose clamped at euglycemic levels after the insulin infusion
to prevent potential hypoglycemia.
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Methods
Experiments were performed on male Munich-Wistar rats
with a weight range of 210 to 280 grams at the time of the
micropuncture measurements. The rats were bred and housed
in an isolated colony at the Veterans Administration Medical
Center, San Diego Animal Research Facility. All rats were
allowed access to food and water ad libitum until the time of the
experiment.
On the morning of the study, the rats were anesthetized with
mactin (Andrew Lockwood Associates) administered intraper-
itoneally (100 mg/kg body wt). A tracheostomy was performed
(PE-240), and PE-50 catheters were placed in the left jugular
vein, left femoral artery, bladder, and left ureter. Arterial blood
pressure was monitored continuously throughout the studies
with a P23dB Gould-Statham pressure transducer and recorded
on a Statham chart recorder. Body temperature was regulated
on a heated table with a servo-controlled heating unit. Further
surgical preparation for rat micropuncture was as previously
described [16j. An infusion of 3H inulin at a rate of =l20 pCi/hr
in saline at a rate of 1,5 mI/hr in non-diabetic and treated
diabetic rats and 2.0 mI/hr in the untreated diabetic rats was
initiated 60 minutes before the first micropuncture measure-
ments and was continued throughout the remainder of the study
as a marker of glomerular ultrafiltration. The differences in base
saline infusion rates was to compensate for the differences in
urine flow in the various groups. Either normal or untreated
diabetic rat donor plasma appropriate for each group was
utilized to restore plasma volume to euvolemic conditions
(insulin-treated diabetic rats received normal donor plasma).
Non-diabetic rats received an infusion of 1% body wt donor
plasma during the 60-minute equilibration period followed by
0.15% body wt/hr donor plasma throughout the remainder of
the study. Untreated or treated diabetic rats received an infu-
sion of 0.8% body wt/hr diabetic donor plasma during the
60-minute equilibration period followed by 0.2% body wt/hr
donor plasma. These protocols were devised to maintain hem-
atocrit and plasma volume approximately equal to those in the
rat prior to anesthesia and surgery [171.
Treatment protocols
1. Control group (CON, N = 6, body wt = 226 9g), Normal
control rats were selected from the colony the day before
micropuncture and maintained with ad libitum access to water
and normal rodent chow (Ralston Purina, St. Louis, Missouri,
USA). The rats were anesthetized and prepared for micropunc-
ture as described above and measurements of glomerular he-
modynamics were performed. After the first period measure-
ments were obtained, 5 U of regular insulin (Humulin R, Eli
Lilly and Co., Indianapolis, Indiana, USA) was infused i.v.
immediately followed by an infusion of 50% dextrose (Elkins-
Simms, Inc., Cherry Hill, New Jersey, USA) at a rate to
maintain euglycemia (80 to 120 mg/dl). The rate of 50% dextrose
infusion ranged from 7 to 10 tl/min. After a 40-minute waiting
period, the micropuncture measurements were repeated. At the
conclusion of the study, the left kidney was removed and wet
tissue weight was obtained.
2. Untreated diabetic group (DM, N = 6, body wt 232 14
g). Seven to 10 days prior to the micropuncture studies the rats
were anesthetized with a short duration anesthetic (65 mg/kg
body wt methohexital sodium, Brevital, Eli Lilly and Co.) and
injected via the tail vein with streptozotocin (65 mg/kg body wt,
Sigma Chemical) to induce insulin dependent diabetes [171. On
the day of the study, the rats were prepared for micropuncture
as previously described and measurements of glomerular hemo-
dynamics were obtained. After the first measurement period,
the same procedure was utilized as in the control for the insulin
administration, except that the dextrose infusion was not
started until blood glucose concentrations were approximately
100 mg/dl. This delay in starting the dextrose infusion was
approximately 30 to 40 minutes. The micropuncture measure-
ments were then repeated,
3. Treated diabetic group (TR DM, N = 6, body wt = 269
6 g). The TR DM group of rats were infused with streptozotocin
in the same fashion as the untreated diabetic group. After the
rats recovered from the Brevital anesthesia, 2 U of heat treated
Ultralente insulin (NOVO Laboratories, Danbury, Connecti-
cut, USA) was administered s.c. During the following 7 to 10
days prior to the micropuncture experiment, blood glucose was
monitored daily in the afternoon (Ames Glucometer, Miles Inc.,
Elkhart, Indiana, USA) and Ultralente insulin was administered
to approximate glycemic control. The daily dose of insulin
ranged from 2 to 8 U. Average daily afternoon blood glucose
concentrations during the treatment period was 172 9 mg/dl.
Preparation for micropuncture was performed as in the previ-
ous groups and the insulin infusion and glucose clamp protocol
was the same as in the control group.
4. Thromboxane A2 synthetase inhibition in non-diabetic rats
(TX-IN CON, N = 5, body wt = 268 8 g). These rats were
prepared for micropuncture similar to the control group with
the exception that Dazmegrel (UK-38485, 1 mg/kg body wt/hr)
was infused i.v. 60 minutes prior to the first micropuncture
measurements and was continued throughout the remainder of
the study. The micropuncture measurement, insulin infusion,
and glucose clamp protocols were the same as in the control
group.
5. Thromboxane A2 synthetase inhibition in untreated dia-
betic rats (TX-IN DM, N = 6, body WI = 226 7 g). This group
was administered streptozotocin in the same fashion as the
untreated diabetic group, DM, and were not treated with insulin
for 7 to 10 days prior to the preparation for micropuncture and
the first micropuncture measurement period. Sixty minutes
before the first micropuncture measurements, Dazmegrel was
infused at 1 mg/kg body wt/hr and continued throughout the
remainder of the study. The micropuncture measurement,
insulin infusion, and glucose clamp protocols were the same as
that of the untreated diabetic group.
Analytical methods
Total filtration rates were calculated as previously described
[161. Whole left kidney filtration fraction was determined from
renal venous blood as previously described [161. Blood glucose
concentrations were monitored with an Ames Glucometer
requiring approximately 30 d of blood per measurement. 3H
counts in plasma, urine, and tubular fluid were monitored on a
model 4300 Packard scintillation counter (Packard Instruments,
Downers Grove, Illinois, USA). Pressure measurements were
obtained with a servo-nulling device (1PM, San Diego, Califor-
nia, USA) with 1- to 3-sm tip pipets [16]. Pressures were
recorded in glomerular capillaries, Bowman's space, proximal
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Table 1. Effect of diabetes and acute insulin infusion on whole kidney function and systemic parameters
MAP Hct glu.
mm Hg % mg/dl
Blood [Nai [K'] GFRL RPFL
mEqiliter mi/mm
CON
CON + I
112 3
112 4
49 1
48 I
99 6
82 7 152 4147 1 5.3 0.34.2 0.2a 0.97 0.051.18 0.l0 3.9 0.44.3 0.3 1.6 0.12.4 0.4
DM
DM + I
108 5
106 4
49 1
48 1
342 15
75 5 151 3151 2 5.3 0.24.0 o.Ia 1.20 0.060.92 0.07 4.3 0.33.3 0.3a 5.6 0.64.3 0.9
TR DM
TRDM + 1
121 4
119 2
45 1
45 1
165 46
80 4 142 4141 2 5.4 0.34.2 0.l 1.06 0.081.03 0.08 5.0 0.54.4 0.5 5.2 0.923 o.3
TX-IN CON
TX-IN CON + 1
108 3
108 3
51 2
48 1
117 12
77 6 149 3155 3 5.5 0.25.5 0.3 0.82 0.070.75 0.08 3.0 0.32.6 0.3 2.1 0.32.1 0.2
TX-In DM
TX-In DM ÷ I
103 2
103 3
49 1
48 1
289 6
101 8 157 5152 6 5.4 0.35.5 0.4 1.04 0.060.77 0.11 3.6 0.42.9 0.3 4.0 0.620 o.4
tubules, and star peritubular capillaries as previously described
by this laboratory [16, 18, 19]. Single nephron filtration rate
(SNGFR) refers to that value defined by fluid collections at the
early distal tubule site localized by the first reappearance of FD
& C green dye after being injected into and transiting the
proximal tubule [20]. Nephron filtration rates estimated from
late proximal tubule collections were not utilized in this study.
Systemic plasma protein concentration was determined by
analysis of femoral artery blood. Efferent arteriolar protein
concentration was obtained from star vessels on the kidney
surface. All collections for systemic and efferent arteriolar
protein concentration were then analyzed by a microadaptation
[21] of the method of Lowry et al [22] as previously described
by this laboratory [16].
Calculations
Oncotic pressure of systemic protein samples (nA) and effer-
ent arteriolar samples (ITE) was determined by the following
relationship
ii = l.74C + 0.28C2
which is a simplification of the empirical relationship defined by
Landis and Pappenheimer [23] and where C represents protein
concentration in gIdl and ir in units of mm Hg
= 2.IC + 0.16C2 + 0.009C3
This equation defines the relationship between oncotic pressure
and protein concentration during normal conditions when =50%
of the total plasma protein is albumin.
Whole kidney plasma and blood flow were determined as
previously described [16, 19]. Single-nephron plasma flow
(SNPF) and single-nephron blood flow (SNBF) was calculated
as previously described from SNGFR values collected at the
early distal tubule site [19].
The determinants of SNGFR were defined as
SNGFR = LpA PP
where LpA represents the glomerular ultrafiltration coefficient
and EFP is the mean effective filtration pressure across the
glomerular capillary. The mean effective filtration pressure and
LpA were determined by an iterative procedure as described
previously from this laboratory [24].
Statistical analysis
Statistical significance between groups of animals was eval-
uated by unpaired t-test, analysis of variance, or Tukey analy-
sis. Two-way analysis of variance was used to evaluate changes
in paired studies (that is, between the first and second periods).
When only one value for a measurement was obtained in a
measurement period, a paired t-test was employed [25, 26].
Statistical significance was considered to be P < 0.05. All data
values are given as means SE [25, 26].
Results
Effects of diabetes and acute insulin infusion on whole kidney
function and systemic parameters
Mean arterial pressure (MAP) was not affected by acute
insulin infusion in control, untreated (DM) or insulin treated
diabetics (TR DM) (Table 1). However, MAP in the insulin
treated diabetic group was significantly greater than either the
controls (CON) or DM rats. Hematocrit was unaltered by acute
insulin infusion in all three groups but hematocrit in the TR DM
group was significantly less than either control or DM rats
(Table 1). Blood glucose concentration in the control group was
99 6 mg/dl during first period measurements and decreased to
82 7 mg/dl (P < 0.05). In DM rats, blood glucose concentra-
tion was 342 15 mg!dl prior to insulin infusion and glucose
clamp and decreased to 75 5 mgldl (P < 0.05, Table 1). In TR
DM rats, blood glucose decreased from 165 46 to 80 4 mg/dl
(P < 0.05). Acute insulin infusion significantly decreased serum
potassium in all three groups whereas serum sodium concen-
tration remained constant. Left (micropunctured) kidney gb-
merular filtration rate significantly increased after acute insulin
infusion in the control rats and decreased after insulin infusion
and glucose clamp in the untreated diabetic rats. The alterations
in GFR were most likely due to the parallel changes in renal
plasma flow. Urine flow is also depicted on Table 1. Wet tissue
kidney weight was 0.88 0.02 g in the control group, 1.16
0.06 g in the DM group (P < 0.05 compared to control), and 0.99
Uv
pilmin
Abbreviations are in the text.
a P < 0.05 compared to respective first period
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Fig. 1. Lffect of acute insulin infusion and glucose clamp (+1) on
SNGFR in control rats (CON), untreated diabetics (DM), and insulin-
treated diabetic rats (TR DM). There were no differences in nephron
filtration rate in the first period among the three groups. Insulin-infusion
significantly increased SNGFR in CON but decreased SNGFR in both
DM and TR DM rats. * P < 0.05 compared to respective first period.
+ P < 0.05 compared to CON first period.
0.01 g in the TR DM group (P < 0.05 compared to both
control and DM groups).
Effects of acute thromboxane inhibitor treatment and insulin
infusion on whole kidney function and systemic parameters
The results of acute insulin infusion on both non-diabetic and
untreated diabetic Tx-IN rats are also depicted on Table 1.
Acute insulin infusion did not significantly alter MAP, Hct,
GFR or RPF in the rats treated with thromboxane synthetase
inhibitor. Blood glucose decreased to a modest degree after
acute insulin infusion in the TX-IN CON group from 117 12
to 77 6 mg/dl to levels not different in the respective periods
in groups Ito 3. Blood glucose also decreased in the TX-IN DM
rats from 289 6 to 101 8 mg/dl after insulin infusion and
glucose clamp (P < 0.05). Thromboxane inhibition in both
control and diabetic rats prevented the decrease in serum
potassium due to acute insulin infusion observed in groups I to
3.
EJfrct of untreated and insulin treated diabetes and acute
insulin infusion on glomerular hemodynamics
Effects on single nephron filtration rate and nephron plasma
flow. The specific effects of acute insulin infusion and glucose
clamp on the dynamics of glomerular ultrafiltration are depicted
in Figures 1 to 5. Acute hyperinsulinemia increased single
nephron filtration rate (SNGFR), based upon collections at the
early distal tubule site, in control rats from 33 2 to 38 2
nllmin (P <0.05, Fig. 1). In the DM rats, SNGFR decreased (31
2 to 24 I nI/mm) as a result of acute hyperinsulinemia and
restoration of blood glucose to euglycemic values (P < 0.05)
and to values significantly less than that of control, non-diabetic
values (P < 0.05, Fig. I). In TR DM rats, SNGFR decreased (34
2 to 26 2 nI/mm) after insulin infusion and glucose clamp to
euglycemic values (P < 0.05, Fig. 1), despite only a small
Fig. 2. Effect of acute insulin infusion and glucose clamp (+1) on
single nephron plasma flow (SNPF) in control rats (CON), untreated
diabetics (DM), and insulin-treated diabetic rats (TR DM). Nephron
plasma flow was not different between CON and DM prior to acute
insulin infusion. However, in the TR DM rats, SNPF in the first period
was significantly greater than either first period CON or DM. Acute
insulin infusion increased SNPF in CON and decreased SNPF in both
DM and TR DM. * P < 0.05 compared to respective first period.
+ P < 0.05 compared to CON first period.
decrease in blood glucose concentration, an effect in contrast to
control, non-diabetic rats. The changes in SNGFR due to acute
insulin infusion were primarily due to the changes in single
nephron plasma flow (SNPF, Fig. 2). In control rats, acute
insulin infusion and glucose clamp increased SNPF from 93 8
to 125 7 nI/mm (P < 0.05, Fig. 2). In untreated diabetic rats,
acute insulin infusion and glucose clamp resulted in a decrease
in SNPF (99 8 to 71 5 nI/mm, P < 0.05). SNPF also
decreased after insulin infusion in the insulin-treated diabetic
rats (143 8 to 96 6 nI/mm, P < 0.05). SNPF was decreased
to values less than control in DM rats after acute insulin
infusion, whereas the values in the TR DM rats were not
different from controls after acute insulin infusion (Fig. 2).
However, SNPF in TR DM rats prior to insulin infusion was
significantly greater than control values for the same period (P
< 0.05). Since insulin infusion and glucose clamp did not
change systemic hematocrit, single nephron blood flow paral-
leled the changes in SNPF.
Effects on the glomerular capillary hydrostatic pressure and
pressure gradient. Glomerular capillary hydrostatic pressure
(PG) was 50 I mm Hg in control rats and increased to 56 I
after insulin infusion (P < 0.05). Since urinary space pressure
did not change after insulin infusion in control, the glomerular
hydrostatic pressure gradient (P) significantly increased (34
Ito 40 1 mm Hg, P < 0.05, Fig. 3). In DM rats, P0 was 45
1 mm Hg prior to insulin infusion and glucose clamp and 40
1 mm Hg after this maneuver (P < 0.05). The change in P in
DM rats paralleled the alteration in P0 (33 1 to 28 1 mm Hg,
P < 0.05, Fig. 3). In TR DM rats, P0 decreased after insulin
infusion and glucose clamp (52 I to 48 1 mm Hg, P < 0.05).
However, due to a significant decrease in urinary space pres-
sure after insulin infusion in TR DM rats which was similar to
the decrease in P0, P did not significantly change with values
of 37 1 mm Hg prior to and 36 1 mm Hg after insulin
infusion and glucose clamp (Fig. 3). It is interesting to note that
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Fig. 3. Effect of acute insulin infusion and glucose clamp (+1) on the
g!o,nerular hydrostatic pressure gradient (P) in control (CON), un-
treated diabetics (DM) and insulin-treated diabetic rats (TR DM). P
was not different between CON and DM, but both were significantly
less than TR DM. After +1, P was increased in CON, decreased in
DM, and unchanged in TR DM. * P < 0.05 compared to respective first
period. + P < 0.05 compared to CON first period.
in the TR DM group, zP was significantly greater than values
measured in the control group, possibly indicating that chronic
insulin treatment contributes to the glomerular hypertension
observed in moderately controlled diabetic rats.
Effects on the glomerular ultrafiltration coefficient, afferent
and efferent arteriolar resistance
The glomerular ultrafiltration coefficient (LpA) decreased in
the control group after acute insulin infusion (0.04 0.005 to
0.03 0.002 nI/sec/mm Hg), partially offsetting the increases in
iP and SNPF, and resulting in a lessor increase in SNGFR than
would be predicted from the changes in SNPF and zP alone.
There were no changes in LpA after insulin infusion and
glucose clamp in either the DM or TR DM rats, and these values
were not different from the control group, first period. Systemic
oncotic pressure (ITA) was 13,3 0.6mm Hg in controls prior to
insulin infusion and decreased to 12.2 0.8 mm Hg after this
maneuver (P < 0.05). In DM rats, ITA was 12.6 0.5 mm Hg
before and decreased to 10.6 0.4 mm Hg after insulin infusion
and glucose clamp (P < 0.05). In TR DM rats, insulin infusion
and glucose clamp did not significantly affect irA, which was
19.0 1.3 versus 17.2 1.0 after insulin infusion. Afferent
arteriolar resistance (AR) significantly decreased in controls
after insulin infusion and glucose clamp (30 4 to 19 2
Gdynes sec cm5, P < 0.05, Fig. 4). In the DM rats the
opposite occurred after insulin infusion and glucose clamp, with
AR increasing from 28 4 to 38 4 Gdynes sec cm5 (P <
0.05, Fig. 4). AR increased in TR DM rats after insulin infusion
and glucose clamp (22 2 to 33 3 Gdynes sec cm', P <
0.05, Fig. 4). Since insulin infusion and glucose clamp did not
affect MAP, the changes in AR most likely contributed to the
observed alterations in single nephron blood flow and G•
Efferent arteriolar resistance in control rats was not signifi-
cantly altered by acute insulin infusion and glucose clamp (19
3 vs. 15 2 Gdynes sec cm5 respectively; Fig. 5). ER was
not changed by insulin infusion in DM rats (15 3 vs. 19 3
Fig. 4. Impact of acute insulin infusion and glucose clamp (+1) on
afferent arteriolar resistance (AR) in control (CON), untreated diabet-
ics (DM) and insulin-treated diabetic rats (TR DM). AR was not
different between CON and DM prior to acute insulin infusion. AR in
TR DM was significantly less than CON values in the first period. After
+1, AR decreased in CON and increased in both DM and TR DM rats
and was the contributing factor to induce changes in SNPF. * P< 0.05
compared to respective first period.
Flu
cl'
Fig. 5. Effect of acute insulin infusion and glucose clamp (+1) on
efferent arteriolar resistance (ER) in control (CON), untreated diabet-
ics (DM) and insulin-treated diabetic rats (TR DM). ER was not
significantly different in the first period among the three groups. Acute
insulin infusion did not significantly alter ER in either CON or DM rats.
In TR DM rats, +1 increased ER to values equivalent to CON first
period. These data are consistent with the alterations in P shown in
Figure 3. * P < 0.05 compared to respective first period.
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Gdynes sec cm5, respectively). However, in TR DM rats,
ER increased from 12 I to 18 2 Gdynes sec cm5 after
acute insulin infusion and glucose clamp (P < 0.05, Fig. 5).
These data indicate that acute insulin infusion exerts opposite
effects on glomerular hemodynamics in diabetic rats (whether
previously treated or untreated with insulin) compared to
non-diabetic controls, and this finding does not appear to be
entirely related to alterations in blood glucose concentration.
Other factors seem to have a role in the observed renal
vasoconstriction.
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Table 2. Effect of acute insulin infusion on glomerular hemodynamics in thromboxane inhibition treated non-diabetic and 7 to 10 day
diabetic rats
Abbreviations are in the text.
a P < 0.05 compared to respective first period
91 7 33 1 0.04 0.01
96 6 31 2 0.05 0.01
116 34± I 0.05±0.01
87 6 29 ia 0.06 0.02
16± I 25±4 15±2
14± 1 27±3 16±2
16±
14±
1
2
20±2
31
12±1
l8±3a
Effect of acute insulin inJision on glornerular hemodynamics
in untreated diabetic and non-diabetic rats with thromboxane
synthetase inhibition
The effect of acute insulin infusion on glomerular hemody-
namics in non-diabetic and 7 to 10 day diabetic rats treated to
inhibit thromboxane synthetase activity are depicted in Table 2.
The SNFR was significantly decreased in TX-IN CON rats
compared to the untreated controls (26 2 vs. 33 2 nI/mm, P
< 0.05) and did not increase after insulin treatment. These
results are quite different compared to that observed in the
CON group in which acute insulin infusion and glucose clamp
increased SNGFR. In the TX-IN DM group, SNGFR was not
different from either the TX-IN CON group or the DM group
(Table 2, Fig. 1). As with the TX-IN CON group, acute insulin
infusion and glucose clamp did not alter SNGFR in the TX-IN
DM rats (Table 2). Acute insulin infusion and glucose clamp did
not significantly affect SNPF in the TX-IN CON rats, results
different from the increase in SNPF observed after insulin
infusion in the CON group (Table 2, Fig. 2). Although SNGFR
did not decrease after insulin treatment in the TX-IN DM
group, there was a significant decrease in SNPF after insulin
infusion, similar to that observed in both the DM and TR DM
groups. Thromboxane inhibition did not affect P in non-
diabetic rats but prevented the increase in zP observed in the
CON group after acute insulin infusion and glucose clamp.
However, thromboxane inhibition did not seem to impair the
action of insulin in DM rats. P decreased after insulin infusion
and glucose clamp in the TX-IN DM group, which was similar
to what was observed in the DM group (P <0.05, Table 2, Fig.
3). Neither LpA or iA were altered by acute insulin infusion or
glucose clamp in thromboxane synthetase-inhibited rats (Table
2). In addition, as opposed to the renal vasodilation observed in
control rats, neither AR or ER were affected by acute insulin
infusion (Table 2). The reason for the decrease in both blood
flow after acute insulin infusion in TX-IN DM rats was the
increases in AR and ER. These data indicate that thromboxane
synthetase inhibition ameliorates the renal vasodilatory effect
of acute insulin infusion in non-diabetic rats, but only partially
prevents the renal vasoconstrictive action of acute insulin
infusion in untreated 7 to 10 day diabetic rats.
Discussion
This study is the first investigation of the action of hyperin-
sulinemia on glomerular hemodynamics. The administration of
insulin in sufficient quantities to require a significant glucose
infusion (200 to 300 mg/hr) in the non-diabetic rat will induce
renal vasodilation and increase both zP and P0. Although acute
hyperinsulinemia will induce significant renal vasoconstriction
in DM rats, there was no decrease in either P or P0 in the
insulin treated diabetic rats, whereas a decrease was observed
in the untreated DM group. These data indicate a role for insulin
in the observed alterations in glornerular hemodynamics, when
insulin treatment is provided in experimental diabetes, and raise
the possibility that the insulin therapy in insulin dependent
diabetes may contribute to the observed glomerular hyperten-
sion.
Previous investigations on glomerular hemodynamics in mod-
erate hyperglycemic insulin-dependent diabetes utilized some
form of insulin therapy. These alterations include increases in
both glomerular filtration rate and renal plasma flow in diabetic
rats with moderate glycemic control (2 U of NPH daily for at
least 3 weeks prior to the study) [31. Increases in glomerular
hydrostatic pressure and the glomerular hydrostatic pressure
gradient have also been demonstrated utilizing micropuncture
techniques by Hostetter et al [3]. Studies by Koch-Jensen et a!
in 10 to 12 week moderately diabetic rats (approximately 300
mg/dl blood glucose concentration) receiving 0.4 U/day of
Ultralente insulin also demonstrated an increase in zP and P0
with no increase in SNGFR [7]. However, in human diabetics
with good glycemic control, neither GFR nor RPF are increased
and proper glycemic control will normalize GFR and RPF in
hyperfiltering diabetics [1]. In untreated diabetes in the rat,
there is no evidence of glomerular hypertension, whereas
glomerular hyperfiltration may or may not persist [3]. This
raises the issue of whether exogenously administered insulin in
concert with moderate hyperglycemia contributes to the devel-
opment and maintenance of glomerular hypertension in insulin
dependent diabetes, or whether glomerular hypertension occurs
only within a limited range of blood glucose concentrations
(that is, 250 to 350 mg/dl).
In the present study, after 7 to 10 days of untreated insulin
dependent diabetes, there was no increase in either glomerular
hydrostatic pressure or the glomerular hydrostatic pressure
gradient. These results are similar to the findings ofHostetteret
al in untreated insulin dependent diabetic rats in which P0 and
AP were not different from non-diabetic values at 10 weeks.
However, at this time point glomerular filtration rate was
significantly lower than in controls, whereas at 7 to 10 days in
our study, SNGFR was not different from non-diabetic rats.
Bank, Lahorra and Aynedjian measured glomerular hemody-
namics in diabetic rats that did not receive insulin 5 to 8 days
SNGFR SNPF
nl/mi,i
TX-IN CON 26 2
TX-INCON+l 28±1
TX-IN DM
TX-IN DM + I
mm Hg
29 2
27 2
LpA
ni/seclmni Hg mm Hg
AR ER
Gdynes sec cm
1166 Tucker et a!: Effect of hyperinsulinemia on he,nodynwnics
prior to the micropuncture study 7 to 10 days after administra-
tion of streptozotocin [4]. The results indicated no increases in
P, but did document a significant increase in P0 and SNGFR.
The data provided by this study and the study of Bank et al [4]
would additionally support that either insulin administration or
a specific level of hyperglycemia is required to increase the
glomerular hydrostatic pressure gradient.
Seven to ten days of insulin treatment sufficient to reduce
blood glucose concentrations to values less than 200 mg/dl did
not increase SNGFR in the present study, but there was a
significant increase in both P0 and zP similar to the observa-
tions of others [3, 271. Although blood glucose was not exces-
sively high in this group, the observation of glomerular hyper-
tension in insulin dependent diabetes was similar to that
observed at 10 to 12 weeks in previous studies in rats with
significantly higher glucose concentrations but with lower daily
insulin doses [31. These data strongly support that exogenous
insulin administration can affect glomerular hemodynamics.
However, these effects are opposite to the observed effects with
acute insulin infusion in diabetic rats.
Acute infusion of 5 units of regular insulin and glucose clamp
to maintain euglycemia in normal, non-diabetic rats resulted in
renal vasodilation and an increase both in P0 and P, as well as
increases in SNPF and SNGFR. If the results are examined in
an isolated fashion, then acute infusion of insulin in normal rats
mimics the changes in glomerular hemodynamics observed in
moderately hyperglycemic rats with small doses of exogenous
insulin. These parallel results occurred without concomitant
hyperglycemia and relate to administration of a dose of insulin
sufficient to produce hyperinsulinemia [28]. These findings are
similar to the study by Cohen, McCarthy and Stoff [29], which
examined the effects of hyperinsulinemia in the isolated per-
fused rat kidney. However, the specific glomerular hemody-
namic alterations were not measured in this previous study [29].
Insulin infusion decreased renal vascular resistance, increasing
both renal perfusate flow and glomerular filtration rate indepen-
dent of any change in perfusate glucose concentration. Also,
insulin infusion and glucose clamp to euglycemia in both insulin
treated and untreated diabetic rats produced the opposite effect.
Hyperinsulinemia in DM rats resulted in vasoconstriction and
reductions in SNGFR, SNPF, and zP compared to both the
pre-insulin infusion period and to normal rats. Although blood
glucose concentration decreased in both DM and TR DM after
acute insulin infusion, the significantly lower blood glucose
concentration in TR DM (165 in TR DM vs. 342 mg/dl in the DM
group) would indicate little correlation between renal hemody-
namic alterations and absolute changes in glucose concentra-
tion. Although the dose of insulin utilized to achieve hyperin-
sulinemia in the pressent study may seem excessive, a recent
study from our laboratory used the same methods [30]. Plasma
insulin concentrations, measured during the second micropunc-
ture period would most like be between 120 and 150 U/ml,
similar to other studies from this laboratory [30] or about three
times basal levels in non-diabetic rats (40 to 50 U/ml).
Previous studies have demonstrated a role for a decrease in
glucose concentration initiating renal vasoconstriction by the
removal of glucose from the distal tubule, reducing luminal
osmotic inhibition of the tubuloglomerular feedback system [4,
31]. However, removal of a inhibitory influence on tubulo-
glomerular feedback could only, at best, offer a partial expla-
nation since it is unlikely that there would be significant
concentrations of glucose in the late proximal tubule of the TR
DM rats. Also, insulin-induced renal vasoconstriction was
observed in diabetic rats without changes in blood glucose
concentration in studies by both Cohen and McCarthy [32] and
Scholey and Meyer [13]. The results of insulin infusion on the
untreated DM group of rats in the present study are somewhat
similar to the findings of Scholey and Meyer in their insulin
infusion study in diabetic rats [13]. However, with the lesser
dose of insulin in the study by Scholey and Meyer in which the
insulin infusion was restricted to doses sufficient to reducing
blood glucose concentration to normal values without the need
for additional glucose administration, there was no decrease in
the nephron plasma flow although renal vasoconstriction did
occur. In the present study, the data indicate that higher doses
of insulin sufficient to produce acute hyperinsulinemia in either
previously insulin treated or untreated diabetic rats will have a
significant effect on nephron blood flow and filtration rate
independent of major blood glucose alterations.
The paradoxical finding that insulin infusion results in renal
vasodilation and increased glomerular hydrostatic pressure in
normal non-diabetic rats whereas the opposite events occur in
both insulin treated and untreated diabetic rats, indicates that
insulin may stimulate release of multiple vasoactive agents, and
that the ratio or net vascular action of vasoconstrictors to
vasodilators are altered in diabetic rats. Previous investigations
have demonstrated that circulating thromboxane A, is in-
creased in insulin dependent diabetes [33, 34], and therefore a
shift in eicosanoid products resulting in net vasodilator in
non-diabetic and vasoconstrictor action in DM rats in response
to hyperinsulinemia could provide an explanation. Thrombox-
ane inhibition prevented both the vasodilatory response in
non-diabetic rats and partially ameliorated the vasoconstrictive
response in diabetic rats to acute insulin infusion, resulting in
no significant SNGFR, GFR or RPF alterations with hyperin-
sulinemia. Since both AR and ER increased after insulin
infusion in the Tx-IN DM rats, only partial protection by
thromboxane inhibition on vasoconstrictor action of insulin was
observed. The fact that thromboxane inhibition also prevented
insulin induced vasodilation suggests that stimulation or sup-
pression of other vasoactive agents occur during Dazmegrel
infusion. The possibility that other vasoactive agents partici-
pate during thromboxane synthetase inhibitor infusion is also
supported by the results where single nephron plasma flow and
nephron filtration rate were significantly decreased in both
control and 7 to 10 day diabetic rats by TX-IN. These findings
in 7 to 10 day DM are substantially different from a recent study
from our laboratory in which an identical thromboxane inhibitor
infusion to 50 to 70 day poorly-controlled (275 to 325 mgldl
blood glucose) diabetic rats also decreased SNGFR but totally
prevented the hyperinsulinemia-induced renal vasoconstriction
[29], suggesting a significant role for thromboxanes during
further development and progression of insulin dependent dia-
betes. It is also indicative that duration of diabetes is an
important consideration in studies of this type.
However, the results in the current study do not provide a
clear explanation of the mechanism of the vasoactive action of
insulin. Insulin has been shown to affect sensitivity to a-adren-
ergic activity in smooth muscle in other vascular beds [10, Il]
as well as condition the response to norepinephrine [12, 13].
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These vasoactive systems may also play a role in the renal
vascular response to acute infusions of insulin and modulate the
net vasoconstriction in diabetic rats versus vasodilation in
non-diabetic rats, and thus requires further investigation.
In summary, acute insulin infusion, sufficient to produce
hyperinsulinemia, and glucose clamp to euglycemic values
increase glomerular capillary hydrostatic pressure, decrease
afferent arteriolar resistance and increase renal plasma flow,
resulting in hyperfiltration in non-diabetic rats. These results
are similar to the changes in glomerular hemodynamics ob-
served in insulin-dependent dIabetic rats which have received
small quantities of insulin for 3 to 12 weeks [3, 7]. In addition,
increases in glomerular capillary hydrostatic pressure and the
glomerular hydrostatic pressure gradient were observed in
insulin-dependent diabetic rats after 7 to 10 days of insulin
treatment, which had doses sufficient to prevent glycosuria.
However, acute hyperinsulinemia in either insulin treated or
untreated diabetic rats resulted in vasoconstriction, an event
which may relate to the triggering of a variety of vasoactive
mechanisms, since it is unlikely that insulin acting alone as a
vasoactive hormone could exert such disparate effects. The
data provide strong evidence that the eicosanoid products,
particularly thromboxanes, participate in the net control of
renal hemodynamics early in insulin dependent diabetes. Insu-
lin exerts complex influences in modulating vascular tone in the
kidney both in diabetic and normal rats and further investiga-
tions are required to define the specific mechanisms.
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